Zdrowie i gospodarka · 04/03/2013
FDA Clears GEREF (Sermorelin Acetate) for Approval
The FDA has determined that two formulations of GEREF (Sermorelin Acetate) injection were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.